Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

4(80.0%)

Phase 1

1(20.0%)

5Total

N/A(4)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT05636124Not ApplicableActive Not Recruiting

Kaneka iED Coil System for the Treatment of Wide Necked Ruptured and Unruptured Intracranial Aneurysms

Role: collaborator

NCT06436092Recruiting

Japanese Coronary Intervention Using Drug Eluting and Perfusion Therapy for Left Main Disease (JDEPTH-LM Registry)

Role: collaborator

NCT04696458Not ApplicableUnknown

Effects of a Multispecies Probiotic on Migraine

Role: collaborator

NCT04113200Not ApplicableCompleted

Comparison of an Alginate Containing Enteral Feed and an Alginate Free Enteral Feed.

Role: collaborator

NCT03853070Unknown

Post Market Clinical Follow-Up for ED Coil / Electro-detach Generator v4

Role: lead

NCT02213562Not ApplicableCompleted

Effect of Chrysanthemum Flower Oil and Its Dose-dependency on Hyperuricemia

Role: collaborator

NCT00980694Phase 1Completed

Bioavailability of Ubiquinol in Huntington Disease

Role: collaborator

All 7 trials loaded